1. Csl Limited (19 from 122 patents)

2. Zenyth Operations Pty. Ltd. (8 from 10 patents)

3. Csl Behring Gmbh (5 from 74 patents)

4. Medimmune Limited (3 from 541 patents)

5. Merck + Co., Inc. (1 from 4,770 patents)

6. Yale University (1 from 1,327 patents)

7. Walter and Eliza Hall Institute of Medical Research (1 from 83 patents)

8. Ralph Raymond Minter (0 patent)

9. Emma Suzanne Cohen (0 patent)

10. Paula Rosamund Harrison (0 patent)

11. Matthew Alexander Sleeman (0 patent)

12. Louis Jerry Fabri (0 patent)

13. Andrew Donald Nash (0 patent)

1. 12071484 - Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein

2. 11345759 - Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies

3. 10513560 - Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies

4. 10106617 - High affinity antibody antagonists of interleukin-13 receptor alpha 1

5. 9856326 - Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies

6. 9856325 - Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies

7. 9777062 - High affinity antibody antagonists of interleukin-13 receptor alpha 1

8. 9758585 - Compositions and methods for targeting type 1 interferon producing cells

9. 9518127 - Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses

10. 9376682 - Method of treating pulmonary disease by administering an antibody to G-CSF

11. 9371388 - High affinity antibody antagonists of interleukin-13 receptor alpha 1

12. 9193793 - Antibodies against G-CSFR and uses thereof

13. 9085628 - Antibody molecule for human GM-CSF receptor alpha

14. 8822644 - Method of treating cancer comprising a VEGF-B antagonist

15. 8613925 - Anti-IL-13Rα1 antibodies and their uses thereof